Skip to main content

Table 1 Demographic data of Shigella -infected patients on the day of enrollment a

From: Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

Features

Study patients (N = 76)

p valueb

Intervention group

Placebo group

n = 39

n = 37

Age, yrs

34.72 ± 13.80

34.97 ± 11.20

0.93

Sex, Male: Female

23:16

19:18

0.66

Body weight, kg

46.04 ± 6.08

45.03 ± 6.96

0.5

Duration of diarrhea, days

3.41 ± 1.46

3.21 ± 0.71

0.97

Frequency of defecation, times/d

4.41 ± 4

5.06 ± 4

0.32

Stool output, g

124.71 ±148.35

83.42 ± 77.69

0.21

Fever, n (%)

18 (46.1%)

16 (43.2%)

0.82

Tenesmus, n (%)

25 (64.1%)

26 (70.3%)

0.63

Abdominal cramping, n (%)

32 (82%)

31 (83.8%)

1.0

Blood in stool, n (%)

17 (43.6%)

17 (45.9%)

1.0

  1. aData are given as mean ± standard deviation, proportion of patients or number of patients (% of total patients in each group).
  2. bStudent-t test or Chi-square test was used to compare between the groups for quantitative or categorical data, respectively. Significance: p≤ 0.05.